Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/21/2005CN1671368A Treatment of depression secondary to pain (DSP)
09/21/2005CN1671367A Aqueous 2, 6-diisopropylphenol pharmaceutical compositions
09/21/2005CN1671366A Use of modulators of the signal transduction path using the protein kinase Fyn for the treatment of tumorous diseases
09/21/2005CN1671365A Improved transdermal delivery system
09/21/2005CN1671364A Hot melt tts for administering rotigotine
09/21/2005CN1671363A Extended release formulation of divalproex sodium
09/21/2005CN1671362A Biodegradable block copolymeric compositions for drug delivery
09/21/2005CN1671361A Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
09/21/2005CN1671360A A pharmaceutical formulation and its use in the treatment of inner ear diseases
09/21/2005CN1671358A Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
09/21/2005CN1671357A Short duration depot formulations
09/21/2005CN1671351A NSAID-containing topical formulations that demonstrate chemopreventive activity
09/21/2005CN1671287A Antimicrobial envelopes
09/21/2005CN1670217A Process for the preparation of pseudomonic acid A antibiotic by microbiological method
09/21/2005CN1670036A Chinese wolfberry polysaccharide extracting method and weight reduction product containing Chinese wolfberry polysaccharide
09/21/2005CN1670030A Preparation of privet total triterpenic acid extract and use thereof
09/21/2005CN1670024A Acyclic nucleoside phosphonate derivatives
09/21/2005CN1670009A Propynyl or dienyl biaromatic compounds
09/21/2005CN1669573A Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparing process thereof
09/21/2005CN1669566A Preparation method of Astragaloside material medicine, the material medicine and preparation
09/21/2005CN1669558A Medicinal composition containing panax ginseng polysaccharide
09/21/2005CN1669557A Bacill calmette-guerin polysaccharide nucleic acid spraying agent and preparation method thereof
09/21/2005CN1669556A Breviscapine preparation and preparing process thereof
09/21/2005CN1669555A Ointment with inflammation diminishing and pain reducing function for treating arthrophlogosis using copper complex compound and preparation method thereof
09/21/2005CN1669554A Liposome vitality conazole preparation
09/21/2005CN1669553A 硫普罗宁注射液及其制备方法 Tiopronin injection and its preparation method
09/21/2005CN1669552A Ethylamine thiourea injection and preparation method thereof
09/21/2005CN1220060C Process for screening active component from plant extract
09/21/2005CN1219881C Human protooncogene and protein encoded therein
09/21/2005CN1219796C Application of N-end amino acid of interferon-tau polypeptide
09/21/2005CN1219790C C60 glucocorticoid and it use
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219777C Thiophene vitamine A
09/21/2005CN1219776C Thiophene substituted amine derivatives as GLYT-1 inhibitors
09/21/2005CN1219768C Quinoline derivatives as inhibitors of MEK enzymes
09/21/2005CN1219764C W-carboxyaryl substituted diphenyl ureas as RAF kinase inhibitors
09/21/2005CN1219763C Substituted indole mannich bases
09/21/2005CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
09/21/2005CN1219748C Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines with taurine chloride and glycine chloride
09/21/2005CN1219556C The use of 4-H-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation
09/21/2005CN1219551C Conjugates made of metal complexes and oligonucleotides
09/21/2005CN1219520C External preparations for treating dermatitis
09/21/2005CN1219519C Exterior used preparation for treating skin trauma
09/21/2005CN1219518C Novel medical use of 2 alpha, 23- dihydroxyl ursolic acid
09/21/2005CN1219517C Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
09/21/2005CN1219516C Medical use of 11, 11'-dideoxy wotixilin
09/21/2005CN1219515C In vivo stain compounds and methods of use to identify dysplastic tissue
09/21/2005CN1219514C Oral medicine preparation with high absorbency
09/21/2005CN1219513C Application of amyl ethyl quin ether hydrochloride
09/21/2005CN1219512C Pharmaceutical compositions containing oxapenem-3-carboxylic acids
09/21/2005CN1219511C Method for curing sepsis
09/21/2005CN1219510C Benzimidazole derivatives as modulators of IgE
09/21/2005CN1219509C Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process
09/21/2005CN1219508C Mucilage antiseptic medicine composition capable of being locally administrated and sustainably released and its preparing method
09/21/2005CN1219449C Addition of tetracyclines to animal foodstuffs
09/20/2005US6947845 Method of identifying molecules that bind to the large ribosomal subunit
09/20/2005US6947844 Modulators of ribosomal function and identification thereof
09/20/2005US6946579 3-carbocycle carbonyl-3-phenylpropionaldehyde intermediates and preparation by alkylating a carbocycle benzyl ketone with an allyl halide and oxidizing the product
09/20/2005US6946561 Desorption; reverse phase chromatography
09/20/2005US6946558 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
09/20/2005US6946557 Cellulose tris (4-chlorophenyl carbamate) on stationary phase in liquid chhromatograhy column separates optical isomers
09/20/2005US6946555 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
09/20/2005US6946554 Process for the preparation of 9-deazaguanine derivatives
09/20/2005US6946492 Use of C2-substituted indan-1-one systems for preparing medicaments for the treatment of obesity
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946490 Medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution; for therapy
09/20/2005US6946489 Substituted biphenyl derivatives
09/20/2005US6946488 Pet food composition for reducing inflammatory response in cats
09/20/2005US6946487 Regulation of intracellular glucocorticoid concentrations
09/20/2005US6946485 Treatment of post-angioplasty restenosis and atherosclerosis with Ras antagonists
09/20/2005US6946484 Controlling cancer by reducing its growth and improving response to therapy
09/20/2005US6946483 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same
09/20/2005US6946482 Motilide compounds
09/20/2005US6946481 Endothelin antagonists
09/20/2005US6946478 Compounds
09/20/2005US6946476 For therapy of metabolic and eating disorders such as obesity and hyperphagia, diabetes
09/20/2005US6946475 Anticancer calcium channel blockers
09/20/2005US6946474 Nitrogen-containing compounds and their use as glycine transport inhibitors
09/20/2005US6946471 2-(2,6-Dichlorophenyl)-Diarylimidazoles
09/20/2005US6946470 Method of treating psychosis in a patient
09/20/2005US6946469 Viricides
09/20/2005US6946468 that inhibit farnesylation of mutant ras gene products; cancer; (2)-2-(2-methoxy-ethyl)-1-((cis)-3-sulfanyl-pyrrolidin-2-ylmethyl)-4-naphthoyl-piperazine
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946465 Immunosuppressive effects of pteridine derivatives
09/20/2005US6946464 Methods of treating and preventing a convulsive state
09/20/2005US6946463 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005US6946460 such as cis-4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]-N-methyl-N-(3-phenyl-2(E)-propenyl)-benzenemethanamine;
09/20/2005US6946459 Crystalline forms of 1s-[1alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl) carbonyl]amino]octahydro-6h-piridazino[1,2-a][1,2]diazepin-1-carboxamide
09/20/2005US6946458 N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
09/20/2005US6946457 easily administering antiviral agents of low toxicity to inhibit the aggregation of hemoglobin S (HbS) and the sickling of erythrocytes; valacyclovir, penciclovir, or famcyclovir
09/20/2005US6946456 Administering compounds which inhibit heat shock protein 90 proteins; methods block Rb negative or deficient cells in the G2/M phase of the cell cycle and rapidly causes their destruction
09/20/2005US6946455 Interstrand crosslinking agents for DNA and compounds therefor
09/20/2005US6946454 Thio-oxindole derivatives
09/20/2005US6946452 Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for treating motion sickness
09/20/2005US6946451 Insulin secretion promoter
09/20/2005US6946450 E.g., beta-L-2'-deoxyadenosine
09/20/2005US6946446 Anti-infective agents useful against multidrug-resistant strains of bacteria
09/20/2005US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance
09/20/2005US6946442 Method of hastening cervical ripening
1 ... 4537 4538 4539 4540 4541 4542 4543 4544 4545 4546 4547 4548 4549 4550 4551 4552 4553 4554 4555 4556 4557 ... 7860